You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
個股熱度排行 | 2月17日港股盤前

根據uSMART輿情監測數據,從16日晚間到17日港股盤前時間段,市場關注指數最高的5只股票是中國銀行、新特能源、爪哇控股、遠大醫藥、中國平安。

2月17日—港股關注排行TOP5

輿情變化榜單

中國銀行

個股K線圖

關注度第一爲中國銀行,該股上個交易日收盤上漲1.94%,報於3.15港元。近5個交易日累計持平。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:

中國銀行:約翰內斯堡分行發行的3億美元綠色票據將於2月17日上市

中國銀行兩筆綠色票據今起上市 共涉資6億美元

新特能源

個股K線圖

關注度第二爲新特能源,該股上個交易日收盤上漲2.13%,報於15.34港元。近5個交易日累計上漲0.13%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

新特能源:新疆新能源擬與華翔股份就開發建設洪洞縣1GW光伏發電項目及光伏支架生產項目進行合作

新特能源附屬擬與洪洞縣人民政府及山西華翔集團簽署投資框架協議書

爪哇控股

個股K線圖

關注度第三爲爪哇控股,該股上個交易日收盤上漲5.91%,報於6.45港元。近5個交易日累計上漲15.18%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

爪哇控股約11.88億港元投得香港淺水灣南灣道私人住宅用地

爪哇集團擬以11.88億元成功投地

遠大醫藥

個股K線圖

關注度第四爲遠大醫藥,該股上個交易日收盤上漲4.96%,報於6.35港元。近5個交易日累計上漲6.01%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

遠大醫藥以2500萬歐元認購ITM約1.31%股份 將使雙方在放射性藥物領域實現強強聯合

遠大醫藥擬2500萬歐元入股德國ITM公司 以在放射性藥物領域實現強強聯合

中國平安

個股K線圖

關注度第五爲中國平安,該股上個交易日收盤上漲3.50%,報於66.55港元。近5個交易日累計上漲1.60%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:

中國平安1月原保費收入合計1364.9億元;興科蓉醫藥獲奧克特琺瑪人血白蛋白中國內地獨家經銷權

中國平安:1月原保險合同保費收入約1364.86億元

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account